RE:Going downI picked up more shares at 9.5 cents today. Market cap is now less than one-third of annual revenues from Biodex by itself. If they can get rid of all debt from the sale of Damar like the CEO has claimed, the stock looks like a good buy at these levels. But obviously I'm putting alot of trust in what the CEO has claimed. I hope he's right.